Calithera Biosciences, Inc. ( CALA) - Key Metrics
CALA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2022Q4 | $0 | -$1.42 | -$1.77 | -$1.77 |
| 2022Q3 | $0 | -$2.01 | -$1.59 | -$1.59 |
| 2022Q2 | $0 | $1.79 | -$1.98 | -$2 |
| 2022Q1 | $0 | -$3.53 | -$4.08 | -$4.08 |
| 2021Q4 | $0 | -$32.01 | -$6.82 | -$6.83 |
CALA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2022Q4 | 0% | -0.57 |
| 2022Q3 | 0% | -0.37 |
| 2022Q2 | 0% | 0.34 |
| 2022Q1 | 0% | -0.57 |
| 2021Q4 | 0% | -0.10 |
CALA
Price: $0
52 week price:
Earnings Per Share: -2.65 USD
P/E Ratio: -3.31
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 883600
Ebitda: -6.6 millionMarket Capitalization: 1462